Pfizer site provides consumers with drug safety information
NEW YORK Pfizer has launched a Web site to provide safety information on its medications, the New York-based drug maker announced Monday.
The site, located at www.Pfizer.com/medicinesafety, contains interactive features on the drug-development process and how drug makers measure safety in drug development. It also has educational videos in which hosts introduce medication safety and explain how to understand risks.
“We want to increase understanding of the industry’s system for ensuring medicine safety,” Pfizer chief medical officer Joseph Feczko said. “Currently, information about drug safety is available through numerous, but fragmented channels, which can be challenging for healthcare professionals and patients as they discuss the risks and benefits of various treatments.”
Bayer denies takeover rumors
FRANKFURT, Germany Reports of Bayer’s imminent takeover appear greatly exaggerated.
The company’s chief executive officer told a German newspaper that it would not be taken over, amid rumors last week that Pfizer sought to acquire it. But Bayer has a number of drugs in its research pipeline, while many of Pfizer’s blockbuster drugs will soon go off patent, facing competition from generic drug makers.
MyMedSchedule now available to the public
INDIANAPOLIS A service that helps people with organ transplants manage their medication schedules has become available to the public.
MyMedSchedule used to be available only in hospitals, reminding organ transplant recipients to take their medications and helping them avoid errors. People who have received transplants often must take several drugs to avoid rejection of the new organs.
Companies such as Community Health Network and the American Society of Health-System Pharmacists offer similar services.